Morishita Soji

モリシタソウジ | Morishita Soji

Affiliation and department：

Research field (1)： Hematology and oncology

Research keywords (4)： next generation sequencer , myeloproliferative neoplasms , gene markers , genetic testing

Research theme for competitive and other funds (9)：

2023 - 2026 骨髄増殖性腫瘍における小胞体ストレス応答分子の細胞腫瘍性に及ぼす影響の解明
2023 - 2026 骨髄増殖性腫瘍幹細胞におけるCD44を中心とする接着因子発現・機能の調節機構解明
2020 - 2023 本態性血小板血症に特異的な転写ネットワークによる細胞腫瘍化メカニズムの解明
2017 - 2020 Clarification of the pathogenesis of myeloproliferative neoplasms based on the identification of genetic factors in familial cases
2016 - 2019 Elucidation of molecular mechanism of cytokie receptor activation by mutant CALR

Show all

Papers (75)：

Satoshi Yamazaki, Yo Mabuchi, Takaharu Kimura, Eriko Grace Suto, Daisuke Hisamatsu, Yuna Naraoka, Ayako Kondo, Yuzuki Azuma, Riko Kikuchi, Hidekazu Nishikii, et al. Activated mesenchymal stem/stromal cells promote myeloid cell differentiation via CCL2/CCR2 signaling. Stem cell reports. 2024
Chiho Furuya, Soji Morishita, Yoshinori Hashimoto, Tadaaki Inano, Tomonori Ochiai, Shuichi Shirane, Yoko Edahiro, Marito Araki, Miki Ando, Norio Komatsu. Impact of non-driver gene mutations on thrombo-haemorrhagic events in ET patients. British journal of haematology. 2024. 204. 1. 221-228
Chiho Furuya, Yoshinori Hashimoto, Soji Morishita, Tadaaki Inano, Tomonori Ochiai, Shuichi Shirane, Yoko Edahiro, Marito Araki, Miki Ando, Norio Komatsu. MPL gene mutation is a possible risk factor for thrombosis in patients with essential thrombocythemia in Japan. Hematology (Amsterdam, Netherlands). 2023. 28. 1. 2229131-2229131
Yoko Edahiro, Tomonori Ochiai, Yoshinori Hashimoto, Soji Morishita, Shuichi Shirane, Tadaaki Inano, Chiho Furuya, Michiaki Koike, Masaaki Noguchi, Kensuke Usuki, et al. Clinical characteristics of Japanese patients with myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis. International journal of hematology. 2023. 118. 1. 47-53
Chang Liu, Misa Imai, Yoko Edahiro, Shuichi Mano, Hiraku Takei, Mai Nudejima, Akira Kurose, Soji Morishita, Miki Ando, Satoshi Tsuneda, et al. Establishment of isogenic induced pluripotent stem cells with or without pathogenic mutation for understanding the pathogenesis of myeloproliferative neoplasms. Experimental Hematology. 2023. 118. 12-20

ｍore...

MISC (36)：

森下総司, 小松則夫. JAK2遺伝子検査が保険適用に. Medical Technology. 2020. 48. 12. 1226-1227
森下総司, 安田肇, 山脇紗耶, 川路英哉, 伊藤昌可, 枝廣陽子, 今井美沙, 向後泰司, 常田聡, 大坂顯通, et al. 骨髄増殖性腫瘍の新規汎用診断マーカー. 日本血液学会学術集会抄録(Web). 2020. 82nd
荒木真理人, 森下総司, 小松則夫. 【造血器腫瘍の遺伝子異常】骨髄増殖性腫瘍の遺伝子異常. 臨床検査. 2019. 63. 7. 790-796
枝廣陽子, 竹井拓, Liu Chang, ぬで島麻衣, 森下総司, 大坂顯通, 荒木真理人, 小松則夫. ヒト造血幹細胞分化に対するJAK2V617Fアレルの負荷の影響(The impact of allelic burden of JAK2V617F on human hematopoietic cell differentiation). Cytometry Research. 2019. 29. Suppl. 68-68
角南義孝, 荒木真理人, 山本誠司, 白根脩一, 堀内祥行, 辻岡一也, 茂櫛薫, 山口茂夫, 今井美沙, 森下総司, et al. 全トランス型レチノイン酸による白血病細胞分化制御因子の同定. Cytometry Research. 2019. 29. Suppl. 76-76

ｍore...

Patents (5)：

Professional career (1)：

博士(工学) (早稲田大学)

Awards (1)：

2019/11 - 第56回ベルツ賞2等賞骨髄増殖性腫瘍の診断と治療の進歩

Association Membership(s) (1)：

Japanese Society of Hematology

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page